{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:19Z","timestamp":1792783339074,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204925"],"award-info":[{"award-number":["82204925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474290"],"award-info":[{"award-number":["82474290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Talent Supporting Program of the China Association of Chinese Medicine","award":["CACM-2024-QNRC2-B39"],"award-info":[{"award-number":["CACM-2024-QNRC2-B39"]}]},{"name":"Financial Project of Fujian Province","award":["X2024004"],"award-info":[{"award-number":["X2024004"]}]},{"name":"Natural Science Foundation of Fujian Province, China","award":["2024J01782"],"award-info":[{"award-number":["2024J01782"]}]},{"name":"Fujian Provincial Science and Technology Project in Traditional Chinese Medicine","award":["2025QNGGA002"],"award-info":[{"award-number":["2025QNGGA002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12325-025-03431-0","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:39:48Z","timestamp":1775543988000},"page":"2645-2667","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative Effectiveness and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Bin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiman","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"1","key":"3431_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12967-023-03881-6","volume":"21","author":"X Pang","year":"2023","unstructured":"Pang X, et al. Transcriptomic analyses of treatment-na\u00efve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis. J Transl Med. 2023;21(1):30.","journal-title":"J Transl Med"},{"issue":"2","key":"3431_CR2","first-page":"181","volume":"15","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis. Chin Herb Med. 2023;15(2):181\u2013200.","journal-title":"Chin Herb Med"},{"key":"3431_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13020-020-0296-z","volume":"15","author":"PD Lu","year":"2020","unstructured":"Lu PD, Zhao YH. Targeting NF-\u03baB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines. Chin Med. 2020;15:15.","journal-title":"Chin Med"},{"issue":"10","key":"3431_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/1744666X.2017.1343668","volume":"13","author":"J Pan\u00e9s","year":"2017","unstructured":"Pan\u00e9s J, Alfaro I. New treatment strategies for ulcerative colitis. Expert Rev Clin Immunol. 2017;13(10):963\u201373.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"3431_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/ibd.20797","volume":"15","author":"SC Ng","year":"2009","unstructured":"Ng SC, Kamm MA. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis. 2009;15(6):935\u201350.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"3431_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12934-020-01417-x","volume":"19","author":"J Wang","year":"2020","unstructured":"Wang J, et al. TAK-242 ameliorates DSS-induced colitis by regulating the gut microbiota and the JAK2\/STAT3 signaling pathway. Microb Cell Fact. 2020;19(1):158.","journal-title":"Microb Cell Fact"},{"key":"3431_CR7","doi-asserted-by":"crossref","unstructured":"Yamamura R and Katsurada T. P1220 Dysbiosis of the gut microbiota and decreased fecal levels of short-chain fatty acid in patients with Ulcerative Colitis: a hospital-based case-control study. J Crohn's Colitis. 2024;(Supplement_1): p. Supplement_1.","DOI":"10.1093\/ecco-jcc\/jjad212.1350"},{"key":"3431_CR8","doi-asserted-by":"publisher","first-page":"1565082","DOI":"10.3389\/fcimb.2025.1565082","volume":"15","author":"F Bu","year":"2025","unstructured":"Bu F, et al. Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment. Front Cell Infect Microbiol. 2025;15:1565082.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"3431_CR9","first-page":"380","volume":"17","author":"Y Yue","year":"2025","unstructured":"Yue Y, et al. Banxia xiexin decoction inhibits colitis-associated colorectal cancer development by modulating STAT3 signaling and gut microbiota. Chin Herb Med. 2025;17(2):380\u201391.","journal-title":"Chin Herb Med"},{"issue":"4","key":"3431_CR10","first-page":"2650","volume":"19","author":"HT Chen","year":"2020","unstructured":"Chen HT, et al. Fecal microbiota transplantation ameliorates active ulcerative colitis. Exp Ther Med. 2020;19(4):2650\u201360.","journal-title":"Exp Ther Med"},{"issue":"5","key":"3431_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20230142","volume":"4","author":"J Lu","year":"2024","unstructured":"Lu J, et al. Recent advances in bacteria-based platforms for inflammatory bowel diseases treatment. Exploration. 2024;4(5):20230142.","journal-title":"Exploration"},{"issue":"17","key":"3431_CR12","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3748\/wjg.v29.i17.2666","volume":"29","author":"P Lahtinen","year":"2023","unstructured":"Lahtinen P, et al. Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: a randomized controlled trial. World J Gastroenterol. 2023;29(17):2666\u201378.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3431_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12934-021-01513-6","volume":"20","author":"H Fang","year":"2021","unstructured":"Fang H, et al. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Microb Cell Fact. 2021;20(1):18.","journal-title":"Microb Cell Fact"},{"issue":"3","key":"3431_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjab165","volume":"16","author":"SC Sarbagili","year":"2022","unstructured":"Sarbagili SC, et al. Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial. J Crohns Colitis. 2022;16(3):369\u201378.","journal-title":"J Crohns Colitis"},{"key":"3431_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102283","author":"D Schierov\u00e1","year":"2020","unstructured":"Schierov\u00e1 D, et al. Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9102283.","journal-title":"Cells"},{"key":"3431_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132753","author":"J B\u0159ezina","year":"2021","unstructured":"B\u0159ezina J, et al. Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis-results of a randomized controlled trial. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10132753.","journal-title":"J Clin Med"},{"issue":"1","key":"3431_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","volume":"21","author":"JW Crothers","year":"2021","unstructured":"Crothers JW, et al. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study. BMC Gastroenterol. 2021;21(1):281.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"3431_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110\u20138 (e4).","journal-title":"Gastroenterology"},{"issue":"2","key":"3431_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321(2):156\u201364.","journal-title":"JAMA"},{"issue":"10075","key":"3431_CR20","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218\u201328.","journal-title":"Lancet"},{"issue":"1","key":"3431_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102\u20139 (e6).","journal-title":"Gastroenterology"},{"issue":"2","key":"3431_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","volume":"7","author":"C Haifer","year":"2022","unstructured":"Haifer C, et al. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2022;7(2):141\u201351.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"3431_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cgh.2024.05.017","volume":"23","author":"C Caenepeel","year":"2025","unstructured":"Caenepeel C, et al. Rigorous donor selection for fecal microbiota transplantation in active ulcerative colitis: key lessons from a randomized controlled trial halted for futility. Clin Gastroenterol Hepatol. 2025;23(4):621\u201331 (e7).","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3431_CR24","doi-asserted-by":"publisher","first-page":"18188","DOI":"10.1038\/s41598-024-68619-w","volume":"14","author":"YJ Zhang","year":"2024","unstructured":"Zhang YJ, et al. Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease. Sci Rep. 2024;14(1):18188.","journal-title":"Sci Rep"},{"key":"3431_CR25","unstructured":"Ma LG, Fu XM and Zhang GJ. Effect of fecal microbiota transplantation combined with mesalazine in the treatment of ulcerative colitis: an observational study. China Community Doctors 2025,41(14):4-6."},{"issue":"12","key":"3431_CR26","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","volume":"71","author":"S Kedia","year":"2022","unstructured":"Kedia S, et al. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut. 2022;71(12):2401\u201313.","journal-title":"Gut"},{"issue":"14","key":"3431_CR27","first-page":"2018","volume":"36","author":"S Niu","year":"2025","unstructured":"Niu S, Jiang D, Ni M. Efficacy of fecal microbiota transplantation combined with dexamethasone in the treatment of ulcerative colitis and its effects on IL-6, CRP, and TNF-\u03b1 levels in patients. Hainan Med J. 2025;36(14):2018\u201323.","journal-title":"Hainan Med J"},{"issue":"10","key":"3431_CR28","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","volume":"11","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2017;11(10):1180\u201399.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"3431_CR29","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00384-020-03599-7","volume":"35","author":"LL Tang","year":"2020","unstructured":"Tang LL, et al. Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis. Int J Colorectal Dis. 2020;35(6):1025\u201334.","journal-title":"Int J Colorectal Dis"},{"key":"3431_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102536","author":"LR Lopetuso","year":"2023","unstructured":"Lopetuso LR, et al. Serial fecal microbiota infusions via colonoscopy for active ulcerative colitis: a feasibility, safety, and translational monocentric Italian study. Microorganisms. 2023. https:\/\/doi.org\/10.3390\/microorganisms11102536.","journal-title":"Microorganisms"},{"issue":"1","key":"3431_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12887-021-03099-9","volume":"22","author":"J Xiong","year":"2022","unstructured":"Xiong J, et al. Development of gut microbiota along with its metabolites of preschool children. BMC Pediatr. 2022;22(1):25.","journal-title":"BMC Pediatr"},{"key":"3431_CR32","doi-asserted-by":"publisher","unstructured":"Madar H et al. [H. Madar, C. Deneux-Tharaux, A. Froeliger, H. Bouchghoul, L. Sentilhes in reply to the article R Cahierc et al. entitled \u00ab\u00a0Evolution of the obstetrical Shock Index in post-partum haemorrhage according to the use of sulprostone\u00bb. Gynecol Obstet Fertil 2023; 51(10): https:\/\/doi.org\/10.1016\/j.gofs.2023.08.001]. Gynecol Obstet Fertil Senol, 2023;51(11\u201312): 545\u20136.","DOI":"10.1016\/j.gofs.2023.08.001"},{"key":"3431_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jconrel.2020.09.011","volume":"327","author":"S Li","year":"2020","unstructured":"Li S, et al. Oral delivery of bacteria: basic principles and biomedical applications. J Control Release. 2020;327:801\u201333.","journal-title":"J Control Release"},{"key":"3431_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020358","author":"C Verdier","year":"2021","unstructured":"Verdier C, et al. An oral FMT capsule as efficient as an enema for microbiota reconstruction following disruption by antibiotics, as assessed in an in vitro human gut model. Microorganisms. 2021. https:\/\/doi.org\/10.3390\/microorganisms9020358.","journal-title":"Microorganisms"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03431-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03431-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03431-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:51:14Z","timestamp":1780116674000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03431-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3431"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03431-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bin Huang,\u00a0Honglin An, Yiman Qiu,\u00a0Tingting Ye,\u00a0Yuqing Huang,\u00a0Mingxuan Zheng,\u00a0Dan Shi, Yanqing Su and Rong Wang have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}